Gov. Doug Ducey announced $150 million in funding for the Center for Advanced Molecular and Immunological Therapies, a center being developed by the University of Arizona Health Sciences.

For the College of Medicine – Phoenix’s Dr. Taben Hale, sharing the success of those she mentors comes with the territory.

Alexandra “Bobbie” Garvin, a postdoctoral research fellow at the UArizona College of Medicine – Phoenix, has been awarded a UArizona Sarver Heart Center grant for her work entitled, “Prohibitin as a Novel Therapeutic Target for Cardiac Fibrosis.”

Dr. Shirin Doroudgar has been selected for a 2022 Career Development Award (CDA) for her research on the molecular changes in the heart that are produced as a result of cardiovascular pathologies that develop over a person’s lifetime.

Researchers from across the Phoenix region met to share discoveries that will improve care for diverse patient populations.

The University of Arizona Postdoctoral Affairs congratulates 2022 Outstanding Postdoctoral Scholar Dr. Erik Blackwood!

The third annual Drug Discovery and Development Summit aims to foster private-public collaboration and commercialization of new discoveries against diseases most burdensome to Arizonans.

Dr. Chris Glembotski, associate dean of research with the UArizona College of Medicine-Phoenix, discovered a compound shown to be effective in reducing severity and recurrence of heart attack, even limiting the damage to the brain during stroke.